ArticleRSC advances2023
Achieving above 24% efficiency with non-toxic CsSnI
Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Harnessing the potential of lead-free BiFeORSC advances · 2026Article
- Performance optimization and machine learning-guided parameter sensitivity analysis of lead-free KGeClRSC advances · 2026Article
- Numerical modeling and performance optimization of all inorganic Pb free novel NaSnClScientific reports · 2025Article
- Advancing photovoltaics with CsRSC advances · 2025Article
- Enhancing perovskite solar cell performance using a BaSnSRSC advances · 2025Article
- Computational modeling and photovoltaic performance evaluation of various ETL/HTL engineered CsCdIRSC advances · 2025Article
- Article
- Multiscale analysis of RbRSC advances · 2025Article
- First-principles investigation and photovoltaic assessment of CsRSC advances · 2025Article
- Examining the contribution of charge transport layers to boost the performance over 26% in SrRSC advances · 2025Article
- DFT insights into bandgap engineering of lead-free LiMClScientific reports · 2025Article
- Scrutinizing the untapped potential of emerging ABSeScientific reports · 2025Article
- Article
- Scrutinizing transport phenomena and recombination mechanisms in thin film SbScientific reports · 2024Article
- Design and Optimization of High-Performance Novel RbPbBrACS omega · 2024Article
- A novel investigation of pressure-induced semiconducting to metallic transition of lead free novel BaRSC advances · 2024Article
- Fullerene-CRSC advances · 2024Article
- Band gap engineering in lead free halide cubic perovskites GaGeXRSC advances · 2024Article
- Improving the efficiency of a CIGS solar cell to above 31% with SbRSC advances · 2024Article
- Lead-free novel perovskite BaHeliyon · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lead toxicity is a barrier to the widespread commercial manufacture of lead halide perovskites and their use in solar photovoltaic (PV) devices. Eco-friendly lead-free perovskite solar cells (PSCs) have been developed using certain unique non- or low-toxic perovskite materials. In this context, Sn-based perovskites have been identified as promising substitutes for Pb-based perovskites due to their similar characteristics. However, Sn-based perovskites suffer from chemical instability, which affects their performance in PSCs. This study employs theoretical simulations to identify ways to improve the efficiency of Sn-based PSCs. The simulations were conducted using the SCAPS-1D software, and a lead-free, non-toxic, and inorganic perovskite absorber layer (PAL),
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.